Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211

Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network

Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015

Adult neurogenesis: from precursors to network and physiology

Abrous, D. N., Koehl, M., & Le Moal, M. (2005) · Physiological Reviews · doi:10.1152/physrev.00055.2003 · Cited by 971

Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850

Integration of metabolism and inflammation by lipid-activated nuclear receptors

Bensinger, S. J., & Tontonoz, P. (2008) · Nature · doi:10.1038/nature07202 · Cited by 827

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors

O’Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 509

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

Rosa, M. D., Radomski, M. W., Carnuccio, R., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91583-e · Cited by 454

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433

Neuroprotective effect of cannabidiol, a non‐psychoactive component from Cannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., & Izzo, A. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02327.x · Cited by 361

Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease With Epilepsy: A Prospective, Open-labeled, Controlled Study

Huang, L., Li, H., Zhong, J., Yang, L. M., Chen, G., Wang, D., Zheng, G., Han, H., Han, X., Long, Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.880944 · Cited by 29

A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors

Miao, Y., Zhao, F., & Guan, W. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae064 · Cited by 29

CBD and the 5-HT1A receptor: A medicinal and pharmacological review

Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28

In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells

Kim, J., Choi, H., Kang, E. K., Ji, G. Y., Kim, Y., & Choi, I. S. (2021) · Molecules · doi:10.3390/molecules26196077 · Cited by 30

Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?

Valeri, A., & Mazzon, E. (2021) · Molecules · doi:10.3390/molecules26206313 · Cited by 26

Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats

Costa, A., Russo, F., Senn, L., Ibatici, D., Cannazza, G., & Biagini, G. (2022) · Pharmaceuticals · doi:10.3390/ph15050495 · Cited by 29

Multiomic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell Lines

Guard, S. E., Chapnick, D. A., Poss, Z. C., Ebmeier, C. C., Jacobsen, J. R., Nemkov, T. G., Ball, K. A., Webb, K. J., Simpson, H. L., Coleman, S. J., et al. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100262 · Cited by 90

Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia

Wu, J., Chen, N., Liu, Y., Godlewski, G., Kaplan, H. J., Shrader, S. H., Song, Z.-H., & Shao, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251677 · Cited by 27

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

DeMarino, C., Cowen, M., Khatkar, P., Cotto, B., Branscome, H., Kim, Y., Sharif, S. A., Agbottah, E. T., Zhou, W., Costiniuk, C. T., et al. (2022) · Cells · doi:10.3390/cells11040723 · Cited by 27

The Anxiolytic Effects of Cannabidiol (CBD)

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Campos, A. C., & Guimarães, F. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00097-1 · Cited by 29

Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice

Watt, G., Chesworth, R., Przybyla, M., Ittner, A., Garner, B., Ittner, L. M., & Karl, T. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172970 · Cited by 26

Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021) · Biomedicines · doi:10.3390/biomedicines9030234 · Cited by 30

Xanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP/PS1 transgenic mice

Zhu, L., Chi, T., Zhao, X., Yang, L., Song, S., Lu, Q., Ji, X., Liu, P., Wang, L., & Zou, L. (2017) · The Journal of Physiological Sciences · doi:10.1007/s12576-017-0561-9 · Cited by 26

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases

Tudorancea, I. M., Ciorpac, M., Stanciu, G. D., Caratașu, C.-C., Săcărescu, A., Ignat, B. E., Burlui, A., Rezuş, E., Creangă-Murariu, I., Alexa‐Stratulat, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102492 · Cited by 28

Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol

Martín‐Sánchez, A., González‐Pardo, H., Alegre-Zurano, L., Castro‐Zavala, A., López-Taboada, I., Valverde, O., & Conejo, N. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110508 · Cited by 25

Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection

Siqueira, A. L. G. D. B., Cremasco, P. V. V., Bahú, J. O., da Silva, A. P., de Andrade, L. R. M., González, P., Crivellin, S., Concha, V. O. C., Krambeck, K., Lodi, L., et al. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.08.006 · Cited by 25

Cannabis-Based Phytocannabinoids: Overview, Mechanism of Action, Therapeutic Application, Production, and Affecting Environmental Factors

Jurga, M., Jurga, A., Jurga, K., Kaźmierczak, B., Kuśmierczyk, K., & Chabowski, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011258 · Cited by 30

Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes

Valenza, M., Facchinetti, R., Menegoni, G., Steardo, L., & Scuderi, C. (2021) · Biomolecules · doi:10.3390/biom11040600 · Cited by 25

Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review

Fearby, N. L., Penman, S. L., & Thanos, P. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063174 · Cited by 27

Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes

Kim, H. J. J., Zagzoog, A., Black, T., Baccetto, S. L., Ezeaka, U. C., & Laprairie, R. B. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.950 · Cited by 22

Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?

Fonseca, C., Ettcheto, M., Bicker, J., Fernandes, M. J., Falcão, A. C., Camins, A., & Fortuna, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101998 · Cited by 31

Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests

Raup‐Konsavage, W. M., Sepúlveda, D. E., Wang, J., Dokholyan, N. V., Vrana, K. E., & Graziane, N. (2023) · Biomedicines · doi:10.3390/biomedicines12010083 · Cited by 24

Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?

Fogaça, M. V., Galve‐Roperh, I., Guimarães, F. S., & Campos, A. C. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030003 · Cited by 24

Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review

Klose, J., Griehl, C., Roßner, S., & Schilling, S. (2022) · Biomolecules · doi:10.3390/biom12050694 · Cited by 23

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s Disease

Zhang, X., Lao, K., Qiu, Z., Rahman, M. S., Zhang, Y., & Gou, X. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181084 · Cited by 24

Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31–35) and Aβ(25–35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations

Chrobak, W., Pacut, D. W., Blomgren, F., Rodin, A., Swenson, J., & Ermilova, I. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00692 · Cited by 23

CBD enhances the cognitive score of adolescent rats prenatally exposed to THC and fine-tunes relevant effectors of hippocampal plasticity

Castelli, V., Lavanco, G., D’Amico, C., Feo, S., Tringali, G., Kuchař, M., Cannizzaro, C., & Brancato, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1237485 · Cited by 23

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

Wang, Y., Hong, Y., Yan, J., Brown, B., Lin, X., Zhang, X., Shen, N., Li, M., Cai, J., Gordon, M. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052757 · Cited by 24

Is the peroxisome proliferator-activated receptor gamma a putative target for epilepsy treatment? Current evidence and future perspectives

Senn, L., Costa, A., Avallone, R., Socała, K., Właź, P., & Biagini, G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108316 · Cited by 23

Cannabinoids and glial cells: possible mechanism to understand schizophrenia

de Almeida, V., & Martins‐de‐Souza, D. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0874-6 · Cited by 23

Substances of abuse and the blood brain barrier: Interactions with physical exercise

Małkiewicz, M. A., Małecki, A., Toborek, M. J., Szarmach, A., & Winklewski, P. J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.026 · Cited by 21

Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review

Schouten, M., Dalle, S., & Koppo, K. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0220 · Cited by 22

Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats.

Silva-Cardoso, G. K., Lazarini-Lopes, W., Primini, E. O., Hallak, J. E., Crippa, J., Zuardi, A., Garcia-Cairasco, N., & Leite-Panissi, C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114588 · Cited by 20

The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system

Maftei, D., Ratano, P., Fusco, I., Marconi, V., Squillace, S., Negri, L., Severini, C., Balboni, G., Steardo, L., Bronzuoli, M. R., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107739 · Cited by 24

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

de Bitencourt, R. M., Takahashi, R. N., & Carlini, E. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638032 · Cited by 23

Protective Effects of Cannabidiol (CBD) against Qxidative Stress, but Not Excitotoxic-Related Neuronal Cell Damage—An In Vitro Study

Jantas, D., Leśkiewicz, M., Regulska, M., Procner, M., Warszyński, P., & Lasoń, W. (2024) · Biomolecules · doi:10.3390/biom14050564 · Cited by 20

Notoginsenoside R2 reduces A β 25-35-induced neuronal apoptosis and inflammation via miR-27a/SOX8/ β -catenin axis

Hu, Y., Wu, L., Jiang, L., Liang, N., Zhu, X., He, Q., Qin, H., & Chen, W. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211041996 · Cited by 21

The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol

dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20

Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

Fernández‐Ruíz, J., Gómez‐Ruíz, M., García, C., Hernández, M., & Ramos, J. A. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.06.021 · Cited by 20

A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease

Cury, R. D. M., da Silva, T., Cezar‐dos‐Santos, F., Fakih, Y. R. C., Narvaez, K. A. R., Gouvea, M. C., Espínola, C., Ferreira, C. F., de Castro, W. A. C., Pamplona, F. A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251389608 · Cited by 22

Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer’s Disease at the Early Stage

Wang, Y., Huang, Y., Ma, A., You, J., Miao, J., & Li, J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01323 · Cited by 21

Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease

Dallabrida, K. G., Bender, J. M. D. O., Chade, E. S., Rodrigues, N., & Sampaio, T. B. (2024) · Brain Sciences · doi:10.3390/brainsci14060592 · Cited by 21

Cannabinoid treats as adjunctive therapy for pets: gaps in our knowledge

Greb, A. C., & Puschner, B. (2018) · Toxicology Communications · doi:10.1080/24734306.2018.1434470 · Cited by 19

Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE , BuChE, and BACE ‐1 Inhibitors Against Alzheimer's Disease by In Silico, In Vitro, and In Vivo Studies

Vitale, R. M., Morace, A. M., D'Errico, A. A., Ricciardi, F., Fusco, A., Boccella, S., Guida, F., Nasso, R., Rading, S., Karsak, M., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8369 · Cited by 18

Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis

Reece, A. S., & Hulse, G. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416721 · Cited by 19

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence

Zavala‐Tecuapetla, C., Luna‐Munguía, H., López‐Meraz, M. L., & Cuéllar‐Herrera, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416181 · Cited by 19

Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function

Towe, S. L., Meade, C. S., Cloak, C. C., Bell, R. P., Baptiste, J., & Chang, L. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09921-y · Cited by 18

Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target

Cavalheiro, E. K. F. F., Costa, A. B., Salla, D. H., da Silva, M. R., Mendes, T. F., da Silva, L. E., Turatti, C. D. R., de Bitencourt, R. M., & Rezin, G. T. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0016 · Cited by 22

Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol

Landucci, E., Mazzantini, C., Lana, D., Giovannini, M. G., & Pellegrini-Giampietro, D. E. (2022) · Toxics · doi:10.3390/toxics10020048 · Cited by 17

Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds

Rybarczyk, A., Majchrzak‐Celińska, A., & Krajka‐Kuźniak, V. (2023) · Antioxidants · doi:10.3390/antiox12122052 · Cited by 18

Functional interactions between cannabinoids, omega‐3 fatty acids, and peroxisome proliferator‐activated receptors: Implications for mental health pharmacotherapies

Jung, T., Hudson, R., Rushlow, W. J., & Laviolette, S. R. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15023 · Cited by 17

In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors

Criscuolo, E., Sciscio, M. L. D., Fezza, F., & Maccarrone, M. (2020) · Molecules · doi:10.3390/molecules26010048 · Cited by 16

Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

Yadav-Samudrala, B. J., Gorman, B. L., Barmada, K. M., Ravula, H., Huguely, C. J., Wallace, E. D., Peace, M. R., Poklis, J. L., Jiang, W., & Fitting, S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1358555 · Cited by 16

Cannabidiol as an Antioxidant

Borges, R. S., & da Silva, A. B. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00093-4 · Cited by 16

Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions

Zhang, X. B., Li, J., Gu, J.-H., & Zeng, Y.-Q. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210331162857 · Cited by 16

Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol

Pandelides, Z., Aluru, N., Thornton, C., Watts, H. E., & Willett, K. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab046 · Cited by 18

The prevalence, mechanism of action, and toxicity of Nigerian psychoactive plants

Fasakin, O. W., Oboh, G., & Ademosun, A. O. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-022-03374-w · Cited by 15

Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke

Meyer, E., Rieder, P., Gobbo, D., Candido, G., Scheller, A., de Oliveira, R. M. W., & Kirchhoff, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112886 · Cited by 18

Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects

Hu, Z., Qin, Z., Xie, J., Qu, Y., & Yin, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116271 · Cited by 15

Cannabis sativa L. Constituents and Their Role in Neuroinflammation

Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019) · Current Bioactive Compounds · doi:10.2174/1573407214666180703130525 · Cited by 15

Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment

Yoo, D. Y., Kim, W., Kim, D. W., Nam, S. M., Jung, H. Y., Kim, J. W., Lee, C. H., Choi, J. H., Won, M., Yoon, Y. S., et al. (2014) · Journal of Veterinary Science · doi:10.4142/jvs.2014.15.1.27 · Cited by 15

PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice

Sonego, A. B., Prado, D. D. S., & Guimarães, F. S. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110367 · Cited by 15

Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15

Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain

Murray, C. J., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119552 · Cited by 12

The two synthetic cannabinoid compounds 4′‐ F‐CBD and HU ‐910 efficiently restrain inflammatory responses of brain microglia and astrocytes

Pereira, M. D. S., Santos, B. M., Giménez, R., Guimarães, F. S., Raisman‐Vozari, R., Bel, E. A. D., & Michel, P. P. (2023) · Glia · doi:10.1002/glia.24489 · Cited by 13

Phytocannabinoids in neuromodulation: From omics to epigenetics

Banerjee, S., Saha, D., Sharma, R., Jaidee, W., Puttarak, P., Chaiyakunapruk, N., & Chaoroensup, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118201 · Cited by 13

Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment

Lazarini-Lopes, W., Silva, R. A. D. V.-D., da Silva-Júnior, R. M. P., Cunha, A. O. S., & Garcia‐Cairasco, N. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.611902 · Cited by 12

Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis

Almeida, T., Santos, M. V., Lopes, L. D. S., Goel, G., de Freitas, R. L., de Medeiros, P. S., Crippa, J. A. S., & Machado, H. R. (2019) · Neurological Research · doi:10.1080/01616412.2019.1651487 · Cited by 12

Cannabidiol and Intestinal Motility: a Systematic Review

Story, G., Briere, C., McClements, D. J., & Sela, D. A. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.101972 · Cited by 11

Anti-inflammatory effects of cannabidiol in early stages of neuroinflammation induced by high-fat diet in cerebral cortex of rats

Opęchowska, A., Karpiuk, K. R., Zahorodnii, A., Harasim‐Symbor, E., Chabowski, A., & Konstantynowicz-Nowicka, K. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116856 · Cited by 12

Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview

Kalsoom, I., Shehzadi, K., Li, H., Wen, H., & Yu, M. (2024) · Topics in Current Chemistry · doi:10.1007/s41061-024-00465-w · Cited by 11

Cannabinoid activation of peroxisome proliferator‐activated receptors: an update and review of the physiological relevance

O’Sullivan, S. E. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.73 · Cited by 11

The Implications of Cannabinoid-Induced Metabolic Dysregulation for Cellular Differentiation and Growth

Podinić, T., Werstuck, G. H., & Raha, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311003 · Cited by 11

Cannabidiol and 5-HT1A Receptors

Fogaça, M. V., Campos, A. C., & Guimarães, F. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00070-5 · Cited by 11

Increasing cannabis use and importance as an environmental contaminant mixture and associated risks to exposed biota: A review

Kennedy, E. K. C., Perono, G. A., Nemez, D. B., Holloway, A. C., Thomas, P. J., Letcher, R. J., Märvin, C. H., Stetefeld, J., Stout, J. M., Peters, O., et al. (2020) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389.2020.1819730 · Cited by 11

Cannabidiol: Science, Marketing, and Legal Perspectives

Wiley, J. L., Gourdet, C., & Thomas, B. F. (2020) · doi:10.3768/rtipress.2020.op.0065.2004 · Cited by 13

Cannabidiol and cognitive functions/inflammatory markers in Parkinson's disease: A double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial)

Mitarnun, W., Kanjanarangsichai, A., Junlaor, P., Kongngern, L., Mitarnun, W., Pangwong, W., & Nonghan, P. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107841 · Cited by 10

Cannabinoids as Regulators of Neural Development and Adult Neurogenesis

Campos, A. C., Paraíso‐Luna, J., Fogaça, M. V., Guimarães, F. S., & Galve‐Roperh, I. (2017) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-49343-5_6 · Cited by 10

Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu, Y., Cong, L., Han, C., Li, B., & Dai, R. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201127104539 · Cited by 10

Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention

Scuderi, C., & Golini, L. (2021) · Animals · doi:10.3390/ani11092584 · Cited by 14

Anti-nociceptive effect of Arbutus andrachne L. methanolic leaf extract mediated by CB1, TRPV1 and PPARs in mouse pain models

Jaffal, S. M., Oran, S. A., & Alsalem, M. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00746-y · Cited by 10

Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors

Ibork, H., Idrissi, S. E., Zulu, S. S., Miller, R. G., Hajji, L., Morgan, A. M., Taghzouti, K., & Abboussi, O. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00671-2 · Cited by 9

New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect

Guldager, M. B., Biojone, C., da Silva, N. R., Godoy, L. D., & Joca, S. R. L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111029 · Cited by 10

Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis

Avalos, B., Kulbe, J. R., Ford, M. K., Laird, A. E., Walter, K., Mante, M., Florio, J. B., Boustani, A., Chaillon, A., Schlachetzki, J. C. M., et al. (2024) · Viruses · doi:10.3390/v16101509 · Cited by 11

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut

Brown, K. J., Funk, K., Barrientos, A. F., Bailey, A., Shrader, S. H., Feng, W., McClain, C. J., & Song, Z. (2024) · Cells · doi:10.3390/cells13191618 · Cited by 9

Cannabidiol/cannabidiolic acid-rich hemp (Cannabis sativa L.) extract attenuates cognitive impairments and glial activations in rats exposed to chronic stress

Kamsrijai, U., Charoensup, R., Jaidee, W., Hawiset, T., Thaweethee-Sukjai, B., & Praman, S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119113 · Cited by 9

Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review

Doumar, H., Mostafi, H. E., Elhessni, A., Touhami, M. E., & Mesfioui, A. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.12.011 · Cited by 9

Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry

Melkumyan, M., & Silberman, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.888345 · Cited by 9

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease

Shade, R. D., Ross, J. A., & Bockstaele, E. J. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949361 · Cited by 9

Cannabidiol effect on long-term brain alterations in septic rats: Involvement of PPARγ activation

Gava, F. F., Carli, R. J. D., Stork, S. D. S., Danielski, L. G., Bonfante, S., Joaquim, L. D. S., Metzker, K. L. L., Mathias, K., dos Santos, D., Daros, G. C., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148771 · Cited by 9

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease

Monteiro, K. L. C., Alcântara, M. G. D. S., de Aquino, T. M., & da Silva‐Júnior, E. F. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.294336 · Cited by 9

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol

de Oliveira, B. S. A., Milanezi, D. S., Gonzaga, P. D. V., Detoni, F. R., & Soriano, R. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12172 · Cited by 10

Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence

Monsalvo-Maraver, L. Á., Ovalle-Noguez, E. A., Nava-Osorio, J., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Tizabi, Y., Aschner, M., Santamarı́a, A., et al. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00694-3 · Cited by 9

Cannabinoids’ Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases

Sharon, N., Yarmolinsky, L., Khalfin, B., Fleisher‐Berkovich, S., & Ben‐Shabat, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126402 · Cited by 9

Cannabidiol and Alzheimer’s disease

Marques, B. L., & Campos, A. C. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.014 · Cited by 9

Effects of Cannabidiol (CBD) on Doxorubicin-Induced Anxiety and Depression-like Behaviors and mRNA Expression of Inflammatory Markers in Rats

Poudel, B., Bany, B. M., Hales, D. B., & Cheatwood, J. L. (2024) · Brain Sciences · doi:10.3390/brainsci14100999 · Cited by 8

A systematic study of molecular targets of cannabidiol in Alzheimer's disease

Patil, N., Patil, K., Jain, M., Mohammed, A., Yadav, A., Dhanda, P. S., Kole, C., Dave, K., Kaushik, P., Razab, M. K. A. A., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241284464 · Cited by 8

Emerging medications and pharmacological treatment approaches for substance use disorders

Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 9

Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ

Islas-Espinoza, A. M., Ramos-Rodríguez, I. I., Escoto-Rosales, M. J., Pizaña-Encarnación, J. M., Morales-Galindo, D. K., Caram‐Salas, N. L., Déciga‐Campos, M., Rodríguez-Palma, E. J., & Granados‐Soto, V. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105378 · Cited by 9

Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease

Mahanta, A. K., Chaulagain, B., Gothwal, A., & Singh, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00465 · Cited by 10

Cannabidiol Reduces Ab-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARc Involvement

Scuderi, C., Valenza, M., Latina, V., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011)

Cannabidiol controls Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

Valenza, M., C, S., L., E. G. A. S., & CARRATU', M. R. (2011) · CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)

PPARγ mediates cannabidiol antiinflammatory and neuroprotective effects in an in vitro model of Alzheimer’s disease.

Scuderi, C., Blasio, A., ESPOSITO, G., STEARDO, L., Valenza, M., Steardo, A., Filippis, D. D., & Iuvone, T. (2009) · IRIS Research product catalog (Sapienza University of Rome)

WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway

Fakhfouri, G., Ahmadiani, A., Rahimian, R., Grolla, A. A., Moradi, F., & Haeri, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.013 · Cited by 119

Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308